AKTIS ONCOLOGY INC (AKTS) Stock Balance Sheet
NASDAQ:AKTS • US01021M1045
20 USD
+0.57 (+2.93%)
At close: Feb 24, 2026
20 USD
0 (0%)
After Hours: 2/24/2026, 8:08:20 PM
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.16M | 29.51M | 128.60M | 88.30M | 44.30M | |||
| Marketable Securities | 260.01M | 68.35M | 0.00 | N/A | N/A | |||
| Receivables | 8.49M | 4.80M | 3.80M | 1.20M | 400.00K | |||
| Inventories | 2.22M | 7.50M | 4.10M | 1.40M | 100.00K | |||
| Other Current Assets | 3.69M | 2.34M | 3.88M | 2.30M | 1.40M | |||
| Total Current Assets | 300.85M | 100.20M | 132.48M | 93.20M | 46.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.87M | 20.92M | 4.87M | 31.20M | 24.30M | |||
| Goodwill | 6.51M | 14.60M | 8.10M | N/A | N/A | |||
| Intangibles | 12.56M | 15.20M | 9.00M | 600.00K | 500.00K | |||
| Other Non-Current Assets | 4.46M | 1.23M | 976.00K | 0.00 | 400.00K | |||
| Total Non-Current Assets | 25.33M | 22.15M | 5.84M | 31.80M | 25.20M | |||
| TOTAL ASSETS | 326.18M | 122.36M | 138.32M | 125.00M | 71.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.63M | 5.28M | 4.79M | 6.00M | 4.00M | |||
| Accounts Payable | 1.92M | 957.00K | 490.00K | 1.20M | 2.10M | |||
| Other Current Liabilities | 9.28M | 0.00 | 1.10M | 0.00 | N/A | |||
| Total Current Liabilities | 18.82M | 6.24M | 5.28M | 7.30M | 6.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 500.00K | 1.30M | 0.00 | 23.20M | |||
| Other Non-Current Liabilities | 61.75M | 11.87M | 927.00K | 300.00K | 600.00K | |||
| Total Non-Current Liabilities | 61.75M | 12.37M | 2.23M | 300.00K | 23.80M | |||
| TOTAL LIABILITIES | 80.58M | 18.61M | 7.50M | 7.60M | 29.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -92.83M | -48.85M | -20.21M | -147.80M | -103.60M | |||
| Additional Paid In Capital | 4.91M | 2.46M | 982.00K | 265.10M | 145.10M | |||
| Common Shares | 333.41M | 150.05M | 150.05M | 100.00K | 0.00 | |||
| Other Shareholders' Equity | 124.00K | 82.00K | 0.00 | N/A | N/A | |||
| Shares Outstanding | 50.65M | 50.65M | 50.65M | 51.20M | 38.00M | |||
| Tangible Book Value per Share | -1.73 | -0.91 | -0.38 | 2.28 | 1.08 | |||
| Total Shareholders' Equity | 245.61M | 103.74M | 130.82M | 117.40M | 41.50M | |||
| TOTAL LIABILITIES AND EQUITY | 326.18M | 122.36M | 138.32M | 125.00M | 71.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | 0.01 | N/A | 0.56 | |||
| Current Ratio | 15.98 | 16.07 | 25.11 | 12.77 | 7.57 | |||
| Return On Assets (ROA) | -13.48% | -23.41% | -42.68% | -35.33% | -50.62% | |||
| Return On Equity (ROE) | -17.91% | -27.61% | -45.12% | -37.61% | -87.08% | |||
All data in USD , ROIC based on taxRate of 0.21